J Gynecol Oncol.
2021 Mar;32(2):e36. 10.3802/jgo.2021.32.e36.
How to start niraparib in real-world Asian ovarian cancer patients?
- Affiliations
-
- 1Division of Medical Oncology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea
- KMID: 2526382
- DOI: http://doi.org/10.3802/jgo.2021.32.e36
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Real-world outcomes of niraparib treatment in patients with ovarian cancer: the first observational multicenter study in China
- An attempt to establish real-world databases of poly(ADP-ribose) polymerase inhibitors for advanced or recurrent epithelial ovarian cancer: the Japanese Gynecologic Oncology Group
- Phase 2 single-arm study on the safety of maintenance niraparib in Japanese patients with platinum-sensitive relapsed ovarian cancer
- The 4th European Society for Medical Oncology Asia Congress: bridging ultimate cancer care with real-world practice for the Asian practitioner in gynecological cancers
- Experience of Chemotherapy in Ovarian Cancer Patients
